Study Comparing 2 Different Formulations of Pantoprazole in Healthy Adults.
NCT00383916 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2007-03-08
Summary
A study comparing 2 different investigational formulations of pantoprazole in healthy adults.
Conditions
- Healthy Subjects
Interventions
- DRUG
-
pantoprazole
Sponsors & Collaborators
-
Wyeth is now a wholly owned subsidiary of Pfizer
lead INDUSTRY
Principal Investigators
-
Medical Monitor · Wyeth is now a wholly owned subsidiary of Pfizer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-10-31
- Completion
- 2006-10-31
More Related Trials
-
Bioequivalence Study of Torrent Pharmaceutical Limited's Pantoprazole Sodium 40 mg Delayed Release Tablets Under Fed Conditions
NCT01418443 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy Volunteers
NCT06552624 ·Status: COMPLETED ·Phase: NA
-
Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers
NCT06098742 ·Status: RECRUITING ·Phase: NA
-
Bioequivalency Study of Ranitidine Tablets 300 mg of Dr. Reddy's Under Fasting Conditions
NCT01131702 ·Status: COMPLETED ·Phase: PHASE1
-
Ramipril 10 mg Capsule in Healthy Subjects Under Fed Conditions
NCT00829530 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)
NCT02529787 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fed Conditions
NCT01499771 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fed Conditions
NCT00803192 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fasting Conditions
NCT00776139 ·Status: COMPLETED ·Phase: NA
-
A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Antacid in Healthy Adults
NCT06507904 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fasting Conditions
NCT00865176 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fasting Conditions
NCT00802828 ·Status: COMPLETED ·Phase: PHASE1
-
Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions
NCT00828321 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Bioequivalence of Famotidine Chewable Tablets and Film-Coated Tablets (0208-144)
NCT00945750 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fasting Conditions
NCT00618254 ·Status: COMPLETED ·Phase: NA
-
Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fasting Conditions
NCT01170169 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fasting Conditions.
NCT01499758 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Cetirizine Hydrochloride 10mg Tablets Under Fed Conditions
NCT00776022 ·Status: COMPLETED ·Phase: NA
-
Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fed Conditions
NCT00803764 ·Status: COMPLETED ·Phase: PHASE1
-
Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fed Condition
NCT01170182 ·Status: COMPLETED ·Phase: PHASE1
-
To Demonstrate the Relative Bioavailability of Atenolol Tablets, 100 mg
NCT00946725 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions:
NCT07201584 ·Status: RECRUITING ·Phase: PHASE1
-
Bioequivalence Study of Allopurinol 300 mg Tablets USP Under Fasting Condition
NCT01603134 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Bioavailability Study of Lisinopril Tablets, 10 mg
NCT01375244 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Rabeprazole Sodium Delayed Release Tablets Under Fed Conditions
NCT01990586 ·Status: COMPLETED ·Phase: PHASE1